Hiroshige Ohashi

506 total citations
34 papers, 389 citations indexed

About

Hiroshige Ohashi is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Hiroshige Ohashi has authored 34 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 13 papers in Cardiology and Cardiovascular Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Hiroshige Ohashi's work include Dialysis and Renal Disease Management (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Renin-Angiotensin System Studies (4 papers). Hiroshige Ohashi is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Blood Pressure and Hypertension Studies (4 papers) and Renin-Angiotensin System Studies (4 papers). Hiroshige Ohashi collaborates with scholars based in Japan. Hiroshige Ohashi's co-authors include Michiya Ohno, Hiroshi Oda, Shinya Minatoguchi, Hisayoshi Fujiwara, Sachiro Watanabe, Nobuyuki Takada, Hiroyasu Ito, Shigeki Sakata, Takako Fujiwara and Genzou Takemura and has published in prestigious journals such as PLoS ONE, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Hiroshige Ohashi

33 papers receiving 378 citations

Peers

Countries citing papers authored by Hiroshige Ohashi

Since Specialization

Citations

This map shows the geographic impact of Hiroshige Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshige Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshige Ohashi more than expected).

Fields of papers citing papers by Hiroshige Ohashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshige Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshige Ohashi. The network helps show where Hiroshige Ohashi may publish in the future.

Co-authorship network of co-authors of Hiroshige Ohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshige Ohashi. A scholar is included among the top collaborators of Hiroshige Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshige Ohashi. Hiroshige Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Levocarnitine Ameliorates Left Ventricular Diastolic as Well as Systolic Dysfunction in Hemodialysis Patients　― Multi-Center Study ― 2019 ·Circulation Reports ·Junko Naito, Hiroshige Ohashi, Michiya Ohno, Masafumi Sugiyama, (unknown), (unknown), Nobuyuki Takada, Tatsuya Kariya, (unknown), Hisato Takatsu, (unknown), (unknown), Ichijiro Murata, Shingo Minatoguchi, (unknown), Hiroyuki Okura, Shinya Minatoguchi	4
2	Relationship between electrical conduction and phasic left atrial function: P-wave signal-averaged electrocardiography and time-left atrial volume curve assessments using two-dimensional speckle-tracking echocardiography 2019 ·Heart and Vessels ·Shinichiro Tanaka, Toshiyuki Noda, Masanori Kawasaki, Tomonori Segawa, (unknown), Takahiro Fuseya, Tomoki Kubota, Makoto Iwama, Kazuhiko Nishigaki, Sachiro Watanabe, (unknown), Hiroshige Ohashi, Shinya Minatoguchi	3
3	Correlation between Renal Function and Common Risk Factors for Chronic Kidney Disease in a Healthy Middle-Aged Population: A Prospective Observational 2-Year Study 2014 ·PLoS ONE ·Michiya Ohno, (unknown), (unknown), (unknown), Hiroshi Sarui, Akihiko Sasaki, Tomonori Segawa, Takahiko Yamaki, Takao Kojima, Hiroshige Ohashi	9
4	Expression of prorenin receptor in renal biopsies from patients with IgA nephropathy. 2014 ·PubMed ·Nagisa Miyazaki, Ichijiro Murata, Genzou Takemura, Hideshi Okada, Hiromitsu Kanamori, (unknown), (unknown), (unknown), (unknown), K Niimi, (unknown), Tatsuhiko Miyazaki, Michiya Ohno, Hiroshige Ohashi, Fumiaki Suzuki, Shinya Minatoguchi	8
5	Long-Term Effects of Spironolactone in Peritoneal Dialysis Patients 2013 ·Journal of the American Society of Nephrology ·Yasuhiko Ito, Masashi Mizuno, Yasuhíro Suzuki, Hirofumi Tamai, Takeyuki Hiramatsu, Hiroshige Ohashi, Isao Ito, Hirotake Kasuga, Masanobu Horie, Shoichi Maruyama, Yukio Yuzawa, Tatsuaki Matsubara, Seiichi Matsuo	65
6	Adiponectin is increased and correlated with the degree of proteinuria, but plasma leptin is not changed in patients with chronic glomerulonephritis 2009 ·Nephrology ·(unknown), Hiroshige Ohashi, Haruko Yokoyama, (unknown), (unknown), Shinya Minatoguchi	8
7	Dual blockade of the rennin–angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis 2008 ·Clinical and Experimental Nephrology ·(unknown), Shinya Minatoguchi, (unknown), Hisayoshi Fujiwara, (unknown), Michiya Ohno, Hiroshi Oda, Hiroshige Ohashi	8
8	Efficacy and pleiotropic effects of a new HMG-CoA reductase inhibitor, Rosuvastatin, in peritoneal dialysis patients with dyslipidemia 2007 ·Nihon Toseki Igakkai Zasshi ·Yoko Kato, (unknown), (unknown), Haruko Yokoyama, Hiroshi Oda, Michiya Ohno, Hiroshige Ohashi	1
9	Renoprotective Effect of the Addition of Losartan to Ongoing Treatment with an Angiotensin Converting Enzyme Inhibitor in Type-2 Diabetic Patients with Nephropathy 2007 ·Hypertension Research ·Hirohiko ABE, Shinya Minatoguchi, Hiroshige Ohashi, Ichijiro Murata, (unknown), (unknown), (unknown), Hisato Takatsu, (unknown), Toshihiko Nagano, (unknown), (unknown), Tatsuo Tsukamoto, Tsutomu Tanaka, (unknown), Hisayoshi Fujiwara	15
10	Hepatocyte Growth Factor Gene Therapy Slows Down the Progression of Diabetic Nephropathy in <i>db/db</i> Mice 2005 ·Nephron Physiology ·(unknown), Genzou Takemura, Ken-ichiro Kosai, Ichijiro Murata, Takamasa Ohno, Tomoyuki Takahashi, Masayasu Esaki, Rumi Maruyama, Takako Fujiwara, Hiroshige Ohashi, Hisayoshi Fujiwara	24
11	Involvement of apoptosis in patients with diabetic nephropathy: A study on plasma soluble Fas levels and pathological findings 2004 ·Nephrology ·(unknown), Shinya Minatoguchi, Hirotake Sano, (unknown), Ichijiro Murata, Genzou Takemura, Takahiro Hirano, Hiroshige Ohashi, Masao Takemura, Takako Fujiwara, Hisayoshi Fujiwara	14
12	C-reactive protein, lipoprotein(a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients 2003 ·American Journal of Kidney Diseases ·(unknown), (unknown), Nobuyuki Takada, Michiya Ohno, Hiroshi Oda, Hiroshige Ohashi	39
13	Angiographic assessment of surgical reconstructions for left ventricular asynergy with indices of abnormally contracting segments. 2001 ·PubMed ·Masahiro Ikeda, Hiroshige Ohashi, (unknown), (unknown), Takahiro Kawai, (unknown)	1
14	Effects of <i>L</i>-Carnitine Supplementation on Cardiac Morbidity in Hemodialyzed Patients 2000 ·American Journal of Nephrology ·Yoshihiro Matsumoto, Motoyoshi Sato, Hiroshige Ohashi, (unknown), (unknown), (unknown), Hiroyasu Ito, Hiroyuki Morita, Izumi Amano	49
15	Lipoprotein(a) as a risk factor for coronary artery disease in hemodialysis patients 1999 ·Kidney International ·Hiroshige Ohashi, Hiroshi Oda, Michiya Ohno, Sachiro Watanabe, Shigeki Sakata	34
16	Apoptosis and Overexpression of Bax Protein and bax mRNA in Smooth Muscle Cells Within Intimal Hyperplasia of Human Radial Arteries 1999 ·Arteriosclerosis Thrombosis and Vascular Biology ·Yukihiro Hayakawa, Genzou Takemura, Jun Misao, Motoo Kanoh, Michiya Ohno, Hiroshige Ohashi, Hisato Takatsu, Hiroyasu Ito, Kazunori Fukuda, Takako Fujiwara, Shinya Minatoguchi, Hisayoshi Fujiwara	19
17	Plasma Soluble Fas and Soluble Fas Ligand in ChronicGlomerulo nephritis 1998 ·The Nephron journals/Nephron journals ·Hirotake Sano, (unknown), Shinya Minatoguchi, (unknown), (unknown), Kazuhiko Nishigaki, Norio Yasuda, (unknown), Masao Takemura, Hiroshige Ohashi, Mitsuru Seishima, Takako Fujiwara, Hisayoshi Fujiwara	16
18	Double filtration plasmapheresis was effective in the treatment of a case of pemphigus vulgaris with multiple organ failure. 1994 ·Nihon Toseki Igakkai Zasshi ·Yukihiko Matsuno, Hiroshi Oda, Hiroshige Ohashi, (unknown), (unknown), (unknown), Kazuko Osada, (unknown)	0
19	Clinical significance of .ALPHA.-human atrial natriuretic peptide in patients on maintenance dialysis. 1991 ·Journal of Japanese Society for Dialysis Therapy ·Hiroshige Ohashi, Hiroshi Oda, Yukihiko Matsuno, (unknown), (unknown), (unknown), Katsumi Ueno, Akira Sugiyama, (unknown), Tetsuo Matsubara, Hitoshi Matsuo, Masazumi Arai	1
20	Acute renal failure caused by nontraumatic rhabdomyolysis 1986 ·Journal of Japanese Society for Dialysis Therapy ·Hiroshige Ohashi, (unknown), (unknown), (unknown), (unknown), Akira Sugiyama, (unknown), Hisayasu Wada, (unknown), (unknown), (unknown), Norihiko Morita	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact